Abstract
We aimed to determine the prevalence of extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli in fecal samples of healthy pigs, and to evaluate their clonality and associated resistance. Forty-nine percent of pigs sampled (n=35/71) in a slaughterhouse in Portugal revealed ESBL-producing E. coli isolates. Most isolates produced CTX-M-1 enzyme (71.4%; n=25/35), followed by CTX-M-9 (11.4%; n=4/35), CTX-M-14 (5.7%; n=2/35), SHV-12 (5.7%; n=2/35), and CTX-M-32 (5.7%; n=2/35). Ninety-four percent of the isolates presented a phenotype of multi-resistance. Most isolates belonged to phylogroups B1 (42.8%; n=15/35) and A (40%; n=14/35). Multilocus sequence typing (MLST) analysis revealed nine sequence types (STs) under six clonal complexes (CCs) and nine singletons, including overrepresentation of CC10 and three new STs (ST2524, ST2525, ST2528). We observed the frequent presence of CTX-M–producing E. coli in pigs at slaughter level, most of them belonging to CC10, commonly recovered from clinical samples.
Introduction
Extended-spectrum beta-lactamases (ESBLs) are bacterial enzymes that confer resistance to a broad range of commonly used β-lactams, including cephalosporins (ceftriaxone, cefotaxime, and ceftazidime), as well as to aztreonam and related oxyimino-β-lactams (Bradford, 2001). Moreover, resistance caused by ESBLs is often associated with resistance to other classes of antibiotics such as aminoglycosides, fluoroquinolones, and trimethoprim-sulfamethoxazole. In addition, most ESBLs genes are plasmid-borne and are often located within transposons and integrons, which facilitates transfer between and within bacterial species (Eckert et al., 2006).
ESBL-producing E. coli are increasingly reported in healthy food-producing animals in several countries in Europe, Asia, and North Africa, and the genotypes sometimes correspond to locally dominant human types (Agersø et al., 2012; Bortolaia et al., 2010; Costa et al., 2009; Escudero et al., 2010; Hiroi et al., 2012; Randall et al., 2011).
Since healthy food-producing animals slaughtered for human consumption can be reservoirs for ESBL strains, the aim of this study was to evaluate the carriage level and type of ESBLs in E. coli obtained from fecal samples in pigs slaughtered in Portugal. In addition, multilocus sequence typing (MLST) was performed based on a greater discriminatory ability and the capacity to define genetically related ESBL-producing E. coli isolates.
Materials and Methods
Samples and bacterial isolates
Seventy-one fecal samples from pigs were collected from September 2008 to March 2009 in a slaughterhouse located in the center of Portugal, where animals from different geographical regions of Portugal are slaughtered. Each fecal sample corresponded to a different flock of animals, ranging from 30 to 50 animals, and were collected directly from the rectum during animal slaughter with the aid of sterile gloves, and transported to the laboratory in a Cary-Blair medium before being processed. The samples were seeded onto Levine agar plates (Levine-CTX plates) supplemented with 2 mg/L cefotaxime (BD product no. 236950, BD Difco™ Tryptic Soy Agar; Oxoid Limited, Basingstoke, UK). Plates were incubated at 37°C for 24 h. Three colonies per sample, with typical E. coli morphology, were selected and identified by classical biochemical methods (Gram-staining, catalase, oxidase, indol, Methyl-Red, Voges-Proskauer, citrate, and urease), and confirmed by the API 20E system (BioMérieux, La Balme-Les Grottes, France).
Antimicrobial susceptibility testing
Susceptibility to 16 antimicrobial agents (ampicillin, amoxicillin+clavulanic acid, cefoxitin, cefotaxime, ceftazidime, aztreonam, imipenem, gentamicin, amikacin, tobramycin, streptomycin, nalidixic acid, ciprofloxacin, sulfamethoxazole/trimethoprim, tetracycline, and chloramphenicol) was tested by the disk-diffusion method in all isolates, and ESBL-phenotypic detection was carried out by double-disk synergy test (CLSI, 2011). E. coli American Type Culture Collection 25922 was used as a quality control strain.
Characterization of antibiotic resistance mechanisms
The presence of genes encoding TEM, OXA, SHV, and CTX-M β-lactamases was studied by polymerase chain reaction (PCR) in all the E. coli isolates using primers and conditions previously reported (Briñas et al., 2003; Jouini et al., 2007). The obtained DNA amplicons were sequenced on both strands, and sequences were compared with those included in the GeneBank database, as well as with those deposited at a website (
MLST and phylogenetic groups analysis
ESBL-containing E. coli isolates were characterized by MLST. The sequences obtained were analyzed using Bionumerics version 3.5 software (Applied Maths, Sint-Martens-Latem, Belgium) and compared against the
The isolates were also classified into one of the four main phylogenetic groups A, B1, B2, and D, following the PCR strategy described previously (Clermont et al., 2000).
Results
β-Lactamases detected in CTX-resistant E. coli isolates
CTX-resistant E. coli isolates were detected in 35 of 71 fecal samples of slaughtered pigs, representing 49.3% of the analyzed samples, and three isolates per sample were identified and their antimicrobial susceptibility profiles determined. All three isolates exhibited the same antimicrobial resistance profile, and for this reason, only one isolate per positive sample was maintained for further studies. All 35 CTX-resistant E. coli isolates exhibited a positive ESBL production test, and the characteristics of the isolates are shown in Table 1. β-Lactamase genes found in the E. coli isolates were as follows: bla TEM-1+bla CTX-M-1 (n=18), bla CTX-M-1 (n=7), bla CTX-M-9 (n=4), bla CTX-M-14 (n=2), bla SHV-12 (n=2), bla TEM-1+bla CTX-M-32 (n=1), and bla CTX-M-32 (n=1). The insertion sequences ISEcp1, IS903, and orf477, surrounding the CTX-M genes, were detected in 26 ESBL-producing E. coli isolates (Table 1). The ISEcp1 sequence was found upstream of the bla CTX-M genes in two of 33 CTX-M E. coli isolates. In these CTX-M isolates, an 80-bp region between the β-lactamase–encoding region and ISEcp1 sequence was detected. In addition, 24 isolates harbored the orf477 or IS903 sequence downstream of the bla CTX-M-1/bla CTX-M-32 or bla CTX-M-9/bla CTX-M-14 genes, respectively.
Additionally bla TEM-1 was detected in these E. coli isolates.
CN, gentamicin; TOB, tobramycin; STR, streptomycin; TET, tetracycline; SXT, sulfamethoxazole-trimethoprim; NA, nalidixic acid; CIP, ciprofloxacin; CHL, chloramphenicol.
Sequences were compared with gyrA and parC genes included in the GenBank database with the accession numbers X06373 for gyrA and M58408 with the modification in L22025 for parC.
MLST, multilocus sequence typing: ST, sequence type; CC, clonal complex. New STs are indicated in boldface.
Antimicrobial resistance
With respect to the pattern of resistance of the ESBL-producing E. coli isolates, most of them (94.2%) presented a phenotype of multidrug-resistance that included antimicrobial agents belonging to at least three different categories, and 22.8% showed resistance to seven different antimicrobial categories (Magiorakos et al., 2012) Table 1.
A wide variety of resistance genes [tet(A), tet(B), aadA, strA, strB, cmlA, floR, aac(3)-II, aac(3)-IV, sul1, sul2, sul3] were detected among our ESBL-producing E. coli isolates (Table 1). Two amino acid changes were identified in GyrA protein (Ser83Leu+Asp87Asn) in six quinolone-resistant isolates, and in ParC protein (Ser80Ile+Glu84Gly) in one isolate. In addition, one amino acid changes was identified in GyrA protein (Ser83Leu) in five nalidixic acid-resistant isolates, and in ParC protein (Ser80Ile) in five nalidixic acid and ciprofloxacin-resistant isolates (Table 1). Twelve isolates harbored class 1 integrons and the gene cassette arrangement dfrA1+aadA1 was identified in all of them. Seven isolates harbored class 2 integrons with the following gene cassettes in their variable regions: aadA1+dfrA1+sat2 (six isolates) and sat1+aadA1 (one isolate). Two E. coli isolates (SU14 and SU80) contained simultaneously class 1 and 2 integrons.
MLST typing
Among the 35 ESBL-producing E. coli isolates, MLST analysis revealed nine different STs under six CCs and nine singletons ST, including overrepresentation of CC10 (31%; n=11/35). Three of the isolates were assigned in a new allele number for the fumC gene, which were included in the MLST database (
The CTX-M-1–producers were distributed into four different CCs (16 isolates) and seven singletons (nine isolates). The CTX-M-9–producers were distributed among two CCs (three isolates) and one singleton (one isolate). The CTX-M-32–producers were distributed among one singleton (two isolates). The CTX-M-14–producers were distributed among two CCs (two isolates). On the other hand, E. coli isolates with different variants of CTX-M, grouped into the same CC, were observed. Three isolates, CTX-M-9– and CTX-M-1–producing E. coli, are associated with the ST58 (CC58); two isolates, CTX-M-14– and CTX-M-9–producing E. coli, are associated with the ST354 (CC354); and three isolates, CTX-M-32– and CTX-M-1–producing E. coli, are associated with the singleton ST1832. The SHV-12–producers were distributed among one CC (one isolate) and one singleton (one isolate; Table 1). Concerning the phylogenetic groups, 42.8% of the 35 ESBL-producing E. coli isolates belonged to the B1 phylogenetic group, 40.0% ofthe isolates to A, and 17.1% of the isolates to D.
Discussion
The detection of ESBL-producing E. coli in 49.3% of the analyzed samples highlights the wide dissemination of these resistant bacteria among healthy pigs for human consumption in Portugal. Similar studies on the prevalence of ESBL-producing E. coli in pigs have been performed at the national level in Portugal and in other European countries. However, significantly lower prevalence rates of ESBL-positive E. coli isolates were described in these reports when compared with our study (Agersø et al., 2012; Escudero et al., 2010; Geser et al., 2011; Gonçalves et al., 2010). Thus, 25% was found in fecal samples of intensive pig farm in Portugal (Gonçalves et al., 2010), while non-ESBL-producing E. coli were found in fecal samples recovered from healthy swine in the north and central region of the country (Machado et al., 2008). Moreover, percentages of 15–26% were described in recent studies in slaughter pigs in Switzerland and Spain, respectively (Escudero et al., 2010; Geser et al., 2011). Some of the variability between our data and previous studies can be related to differences in geographical conditions or even differences in methodologies. However, the wide dissemination of ESBL-producing E. coli among fecal isolates of healthy food-producing animals found in our study is a problem of food safety, and it is important to analyze the factors that could contribute to this situation.
Our results confirm that CTX-M-1 enzyme was the most dominant ESBL, followed by CTX-M-9. In previous studies, performed in Spain and Denmark, a high prevalence of CTX-M-1 was also reported in E. coli isolates recovered from healthy swine (Agersø et al., 2012; Blanc et al., 2006). Moreover, also in Spain, Briñas et al. (2005) described E. coli isolates recovered from sick pigs that were found to harbor CTX-M-14–, CTX-M-32–, and SHV-12–encoding genes (Briñas et al., 2005). In our study, isolates from healthy pigs also showed CTX-M-14, CTX-M-32, and SHV-12 β-lactamases. The occurrence of ESBL-producing E. coli in Portugal was reported in 2010 in a study conducted in an intensive pig farm in the north of the country by Gonçalves et al. (2010). In that study, the only ESBL-encoding genes detected were the CTX-M-1. In addition, ESBL-producing E. coli, particularly those producing CTX-M type ESBLs, are commonly associated with human healthcare and community (Guimarães et al., 2009; Mendonça et al., 2007).
The plasmid-located bla CTX-M genes have been previously found associated to the ISEcp1 or the IS903 insertion sequences (Lartigue et al., 2007). In our study, the bla CTX-M-1 gene has been identified as associated with the ISEcp1 sequence in two E. coli isolates, and the IS903 element was found downstream of bla CTX-M-9 (three isolates) and bla CTX-M-14 (one isolate). The presence of these insertion sequences upstream and downstream of the bla CTX-M genes may play an important role in the mobilization and expression of different β-lactamase genes (Eckert et al., 2006).
Resistance to quinolones in E. coli is primarily related to mutations in GyrA, and additional mutations in ParC also produce higher levels of resistance. The substitutions Ser83Leu and Asp87Asn (GyrA) and Ser80Ile (ParC) were the most frequently detected in our quinolones-resistance E. coli isolates and similar findings were reported by others (Drago et al., 2010; Jouini et al., 2007; Leflon-Guibout et al., 2004).
Class 1 and/or class 2 integrons carrying resistance gene cassettes were detected in 48.6% of E. coli isolates. Similar to our results, class 1 integrons carrying dfrA1 and aadA1 cassettes were frequently observed in E. coli isolates from pigs in Europe (Guerra et al., 2003; Kadlec and Schwarz, 2008; Sunde, 2005). In addition, in class 2 integrons, the aadA1 cassette gene was found in association with the arrangements dfrA1-sat2 or sat1. These gene combinations have also been frequently detected among resistant E. coli isolates from pigs (Kadlec and Schwarz, 2008; Sunde, 2005). The increased prevalence of integrons observed in bacteria isolated from healthy swine for human consumption is a cause for concern, and even if they do not have the capacity for genetic mobilization, integrons can be disseminated through plasmids or transposons to other bacteria.
A great heterogeneity of MLST types was observed among our ESBL-producing E. coli isolates. CC10 and CC155 were the most common CCs. Some ESBL-producing E. coli clones of phylogroups A and B1 associated with CC10 and CC155, respectively, have been increasingly found in human clinical samples in Spain (Valverde et al., 2009). CC10 is overrepresented among isolates of phylogroup A, and is frequently identified among ESBL- and non-ESBL-producing E. coli isolates from fecal samples of healthy people (Leflon-Guibout et al; Valverde et al., 2009), enterotoxigenic E. coli isolates from community-based populations (Turner et al., 2006), and ESBL-producers E. coli causing UTIs (Oteo et al., 2009; Valverde et al., 2009). It is also important to underline the incidence of two ST101 E. coli isolates in our study, which had recently been associated with clinical isolates with New Delhi metallo-β-lactamase (NDM) enzymes in the United Kingdom, Pakistan, and Canada (Nordmann et al., 2011).
Moreover, six of our ESBL-producing E. coli isolates were included in three new sequences type, and all of them were assigned to phylogroup B1. Three of these isolates were identified in a new allele number for the fumC gene that originated a new ST (ST2528). Moreover, a new combination of alleles was obtained for two isolates and designated as ST2524 and ST2525. Through the MLST database, we found that ST656 (CC10) and ST8 (CC165) have a higher homology to ST2524 and ST2525, respectively. The ST2524 is a single locus variant of ST656 which belongs to CC10, while ST2525 is a double locus variant of ST8 included in CC165. CCs are defined as a group of multi-locus genotypes in which every genotype shares at least five loci in common with at least one other member of the group (Feil et al., 2001); the new STs, ST2524 and ST2525, most likely belong to CC10 and CC165, respectively.
E. coli isolates belonging to the most common ST or CC could carry almost all of the ESBL types known. For example, in a study performed in Spain, the ST10 complex (the most frequent in this study and also in the MLST database) carried five different ESBLs (CTX-M-14, SHV-12, CTX-M-9, CTX-M-15, and CTX-M-32) (Oteo et al., 2009). In a French study, ST10 complex isolates (associated with ST131) were found to be the most prevalent among fecal samples from healthy carriers of nalidixic acid–resistant (but ESBL-negative) E. coli (Leflon-Guibout et al., 2008).
Conclusion
This study demonstrated a high prevalence of ESBL-producing E. coli recovered in pigs slaughtered for human consumption in Portugal. Our findings raise important questions for human health due to the possible spreading of ESBL-producing E. coli via foodborne transmission or even by environmental pathways, such as farm waste. From a food safety perspective, the presence of ESBL-producing E. coli in fecal samples of pigs represents a risk for carcass contamination at slaughter and therefore also the potential for contamination of retail meat products. Although the bacteria can be easily killed during the cooking process, if the meat is not thoroughly cooked E. coli might survive and may lead to colonization of humans with ESBL-producing E. coli. Further investigation is required to understand the magnitude of this selection and to assess the risk of zoonotic transmission via the food chain and by contact with animals.
Footnotes
Acknowledgments
S.R. and D.D. were supported by national funds of the Fundação para a Ciência e Tecnologia (FCT) (SFRH/BD/47706/2008 and SFRH/ BD/80001/2011, respectively), co-financed by POPH QREN Type 4.1–Advanced Training, and subsidized by the European Social Fund and National Funds of Ministry of Science and Technology for High Education (MCTES). N.S. was supported by Programa Ciência (2008), co-financed by POPH QREN Type 4.2–Employment Promotion Scientific, and subsidized by the MCTES.
Disclosure Statement
No competing financial interests exist.
